Nanomaterials exhibit unique physical and chemical properties that differ from their bulk counterparts. These properties can lead to new risks and benefits, making it essential to have a regulatory framework like REACH to evaluate and manage these materials effectively. Given their small size and high reactivity, nanomaterials can interact with biological systems in novel ways, necessitating comprehensive assessment under REACH.
